Blood Shortage Causes Surgery Delays in New England
While periodic, localized blood shortages are not uncommon, this shortage is ‘unprecedented in its scope’
Diagnosis & Disease Information
10 Things Your Patients Should Know About Anemia
Though anemia is the most common blood disorder in the US, are patients educated on how it affects the body and how they have to manage it? Here is what they should know about anemia, how it is caused, and who is at risk.
Renoprotective Effect of SGLT2 Inhibitors Mediated Largely by Hematocrit
Increases in the proportion of red blood cells mediates the reduction in renal risks associated with SGLT2 inhibitor therapy in patients with type 2 diabetes and cardiovascular disease, a study found.
Erythropoietin May Increase Hip Fracture Risk in Hemodialysis Patients
Higher erythropoietin doses may be an independent risk factor for hip fractures in hemodialysis patients, data suggest.
FDA Approves Single Dose Option for Iron Replacement Therapy Injectafer
For patients weighing at least 50kg, Injectafer may be administered as a single dose option of 15mg/kg body weight up to a maximum of 1000mg intravenously.
Vadadustat Noninferior to ESA in Efficacy, But Not CV Safety in NDD-CKD
Vadadustat and darbepoetin alfa had similar hematologic efficacy in patients with nondialysis-dependent CKD (NDD-CKD) and those on dialysis, but vadadustat was associated with a higher risk of major adverse cardiovascular events in patients with NDD-CKD.
Study IDs Most Effective Strategies to Reduce Fibroblast Growth Factor 23
Circulating FGF23 starts to rise in early stage CKD before the development of other abnormalities such as high parathyroid and phosphate levels and low calcium and 1,25(OH)2D levels.
Investigators Identify Predictors of ESA Use in Nondialysis CKD
An analysis of contemporary ESA utilization among patients with anemia of nondialysis-dependent chronic kidney disease may help identify optimal candidates for treatment.
Study: Roxadustat Effectively Treats Anemia Across CKD Stages
Roxadustat reduced the need for rescue therapy among patients with any stage of chronic kidney disease.
Anemia of Chronic Kidney Diseases Burden High Globally, Treatment Rates Low
Comorbidities and advanced CKD were prevalent among the approximately 275,000 patients with anemia of CKD from the international DISCOVER CKD cohort.
- Loading...
Loading...
Next post in NKF 2021 Spring Meeting
Loading... 
Loading...